|
🐜
|
Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis.
17 auth.
Jeffrey A. Cohen,
F. Barkhof,
G. Comi,
H. Hartung,
B. Khatri,
X. Montalban,
J. Pelletier,
R. Capra,
P. Gallo,
G. Izquierdo,
...
K. Tiel‐Wilck,
A. de Vera,
James Jin,
T. Stites,
Stacy Wu,
S. Aradhye,
L. Kappos
|
11 |
2010 |
11
🐜
|
|
🐜
|
Correlation between brain volume loss and clinical and MRI outcomes in multiple sclerosis
10 auth.
E. Radue,
F. Barkhof,
L. Kappos,
T. Sprenger,
D. Häring,
A. de Vera,
...
Philipp von Rosenstiel,
J. Bright,
G. Francis,
Jeffrey A. Cohen
|
7 |
2015 |
7
🐜
|
|
🐜
|
Fingolimod in relapsing multiple sclerosis: An integrated analysis of safety findings.
8 auth.
L. Kappos,
Jeffrey A. Cohen,
W. Collins,
A. de Vera,
Lixin Zhang-Auberson,
S. Ritter,
...
Philipp von Rosenstiel,
G. Francis
|
6 |
2014 |
6
🐜
|
|
🐜
|
Impact of fingolimod therapy on magnetic resonance imaging outcomes in patients with multiple sclerosis.
14 auth.
E. Radue,
P. O'Connor,
C. Polman,
R. Hohlfeld,
P. Calabresi,
K. Selmaj,
N. Mueller-Lenke,
C. Agoropoulou,
Frederick Holdbrook,
A. de Vera,
...
Lixin Zhang-Auberson,
G. Francis,
P. Burtin,
L. Kappos
|
6 |
2012 |
6
🐜
|
|
🐜
|
Secukinumab is Superior to Ustekinumab in Clearing Skin in Patients with Moderate to Severe Plaque Psoriasis (16-Week CLARITY Results)
12 auth.
J. Bagel,
J. Nia,
P. Hashim,
M. Patekar,
A. de Vera,
S. Hugot,
...
K. Sheng,
S. Xia,
I. Gilloteau,
Elisa Muscianisi,
A. Blauvelt,
M. Lebwohl
|
5 |
2018 |
5
🐜
|
|
🐬
|
The influence of patient demographics, disease characteristics and treatment on brain volume loss in Trial Assessing Injectable Interferon vs FTY720 Oral in Relapsing–Remitting Multiple Sclerosis (TRANSFORMS), a phase 3 study of fingolimod in multiple sclerosis
F. Barkhof,
R. de Jong,
N. Sfikas,
A. de Vera,
G. Francis,
Jeffrey A. Cohen
|
5 |
2014 |
5
🐬
|
|
🐜
|
Development and validation of a Bayesian survival model for inclusion body myositis
8 auth.
G. Capkun,
Jens Schmidt,
Shubhro Ghosh,
H. Sharma,
T. Obadia,
A. de Vera,
...
V. Risson,
B. Amzal
|
1 |
2019 |
1
🐜
|
|
🐬
|
[Descriptive study of a serie of patients affected by progressive supranuclear palsy].
V. Villanueva-Haba,
M. Garcés,
A. de Vera,
C. Valero,
J. Burguera
|
0 |
2001 |
0
🐬
|
